fda changes to tirzepatide says compounding pharmacies can keep making weight-loss med tirzepatide, for now Tirzepatide vs. Semaglutide: What You

People also use it to treat overweight and obesity

semaglutide on HbA1c and weight in GLP-1 RA Nave patients with T2D

The interest is understandable

Rare Vision Events (NAION) Rare vision complications, including non-arteritic anterior ischemic optic neuropathy (NAION), have been reported in post-marketing data

While a survey found that several states were considering adding Medicaid coverage of weight loss medications, studies show that only a limited number of states cover weight loss medications in Medicaid, with some states only covering the drugs for severe obesity, with comorbidity, or other conditions